In this context, however, this effect is not countered by repairing enzymes, such as OGG1, establishing a pro-inflammatory/prooxidative cytoplasmic molecular pattern that leads to the release of IL-18 and IL-33 from PBMCs obtained from unstable/exacerbated COPD patients. This evidence concerns the gene OGG1 and chronic obstructive pulmonary disease.